A role for vagal activity in preventing the suppression of glucagon secretion by GLP-1 during hypoglycemia

Autonomic signaling suppresses somatostatin secretion, crucial for paracrine stimulation of glucagon secretion. SST mediates GLP-1-induced inhibition of glucagon secretion, but autonomic signaling may interfere with this mechanism. Activation of cholinergic pathways in a preparation with prepancreatic parasympathetic structures suppresses SST secretion in response to GLP-1 and potentiates glucagon secretion during hypoglycemia. These findings support the clinical importance of autonomic signaling in regulating pancreatic hormone secretion and hypoglycemia risk in some patients on GLP-1 receptor agonists.

Authors

Institutions

Publication Details

Journal
American Journal of Physiology-Endocrinology and Metabolism
Published
2026-04-13
DOI
https://doi.org/10.1152/ajpendo.00236.2025
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A role for vagal activity in preventing the suppression of glucagon secretion by GLP-1 during hypoglycemia

Carolina B. Lobato, Jens Juul Holst, Amalie B. E. Nielsen
American Journal of Physiology-Endocrinology and Metabolism
Diabetes Treatment and Management
article

A role for vagal activity in preventing the suppression of glucagon secretion by GLP-1 during hypoglycemia

Carolina B. Lobato, Jens Juul Holst, Amalie B. E. Nielsen
article en

Abstract

Autonomic signaling suppresses somatostatin secretion, crucial for paracrine stimulation of glucagon secretion. SST mediates GLP-1-induced inhibition of glucagon secretion, but autonomic signaling may interfere with this mechanism. Activation of cholinergic pathways in a preparation with prepancreatic parasympathetic structures suppresses SST secretion in response to GLP-1 and potentiates glucagon secretion during hypoglycemia. These findings support the clinical importance of autonomic signaling in regulating pancreatic hormone secretion and hypoglycemia risk in some patients on GLP-1 receptor agonists.

American Journal of Physiology-Endocrinology and MetabolismVol. 330(5)
University of Copenhagen (DK), Amager Hospital (DK), Copenhagen University Hospital (DK)
“la Caixa” Foundation, Novo Nordisk Fonden, Novo Nordisk Foundation Center for Basic Metabolic Research
Good health and well-being
Openalex Percentile: Top 28%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.